Profound Medical Corp Stock Debt To Equity
| PROF Stock | USD 5.50 0.05 0.90% |
Fundamental analysis of Profound Medical allows traders to better anticipate movements in Profound Medical's stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Profound Medical Corp Company Debt To Equity Analysis
Profound Medical's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Profound Medical Debt To Equity | 0.02 % |
Most of Profound Medical's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Profound Medical Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, Profound Medical Corp has a Debt To Equity of 0.018%. This is 99.97% lower than that of the Health Care Equipment & Supplies sector and 99.96% lower than that of the Health Care industry. The debt to equity for all United States stocks is 99.96% higher than that of the company.
Profound Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Profound Medical's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Profound Medical could also be used in its relative valuation, which is a method of valuing Profound Medical by comparing valuation metrics of similar companies.Profound Medical is currently under evaluation in debt to equity category among its peers.
Profound Fundamentals
| Return On Equity | -0.66 | ||||
| Return On Asset | -0.39 | ||||
| Profit Margin | (2.69) % | ||||
| Operating Margin | (4.26) % | ||||
| Current Valuation | 128.4 M | ||||
| Shares Outstanding | 30.05 M | ||||
| Shares Owned By Insiders | 17.34 % | ||||
| Shares Owned By Institutions | 47.44 % | ||||
| Number Of Shares Shorted | 614.11 K | ||||
| Price To Book | 3.29 X | ||||
| Price To Sales | 14.25 X | ||||
| Revenue | 10.68 M | ||||
| Gross Profit | 8.02 M | ||||
| EBITDA | (33.06 M) | ||||
| Net Income | (27.82 M) | ||||
| Cash And Equivalents | 46.21 M | ||||
| Cash Per Share | 2.21 X | ||||
| Total Debt | 5.12 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 17.36 X | ||||
| Book Value Per Share | 1.69 X | ||||
| Cash Flow From Operations | (23.45 M) | ||||
| Short Ratio | 20.40 X | ||||
| Earnings Per Share | (1.21) X | ||||
| Target Price | 12.1 | ||||
| Number Of Employees | 142 | ||||
| Beta | 0.27 | ||||
| Market Capitalization | 169.01 M | ||||
| Total Asset | 70.23 M | ||||
| Retained Earnings | (245.02 M) | ||||
| Working Capital | 62.5 M | ||||
| Current Asset | 9 K | ||||
| Current Liabilities | 761 K | ||||
| Net Asset | 70.23 M |
About Profound Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Profound Medical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Profound Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Profound Medical Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Check out Profound Medical Piotroski F Score and Profound Medical Altman Z Score analysis. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profound Medical. If investors know Profound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Profound Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Profound Medical Corp is measured differently than its book value, which is the value of Profound that is recorded on the company's balance sheet. Investors also form their own opinion of Profound Medical's value that differs from its market value or its book value, called intrinsic value, which is Profound Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Profound Medical's market value can be influenced by many factors that don't directly affect Profound Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.